Clinical Trials Directory

Trials / Completed

CompletedNCT01900418

Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
Female
Age
21 Years – 99 Years
Healthy volunteers
Not accepted

Summary

For post-menopausal women diagnosed with hormone-receptor positive breast cancer tumors, aromatase inhibitors (AIs) are the standard adjuvant hormone treatment to prolong disease-free survival and time-to-recurrence. Unfortunately, joint pain/stiffness/achiness (arthralgia) is a common side-effect of AIs. This "proof-of-concept" study explores how an evidence-based physical activity (PA) program- the Arthritis Foundation's Walk with Ease (WWE) program- can be adapted for breast cancer survivors on AI therapy to: 1) Help them maintain or achieve recommended levels of PA, 2) reduce their joint pain/stiffness/achiness, and 3) thereby enable them to remain on AI therapy as prescribed.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWalk with EaseAn evidence-based walking program

Timeline

Start date
2013-08-01
Primary completion
2015-10-01
Completion
2016-06-01
First posted
2013-07-16
Last updated
2016-08-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01900418. Inclusion in this directory is not an endorsement.

Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy (NCT01900418) · Clinical Trials Directory